Cognitive effects of darifenacin and oxybutynin extended release in volunteers aged 60 and over

Trial Profile

Cognitive effects of darifenacin and oxybutynin extended release in volunteers aged 60 and over

Completed
Phase of Trial: Phase II

Latest Information Update: 12 Jul 2007

At a glance

  • Drugs Darifenacin; Oxybutynin
  • Indications Overactive bladder
  • Focus Pharmacodynamics
  • Sponsors Novartis
  • Most Recent Events

    • 12 Jul 2007 Status changed from in progress to completed.
    • 10 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top